Atypical Depression: What the Clinical Specifier Means
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Atypical depression describes a recognizable pattern of depressive symptoms, formally called “with atypical features” in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). The defining feature is mood reactivity: mood can brighten temporarily after something positive happens, even while a clinically significant depressive illness continues. Increased appetite, excessive sleep, a heavy feeling in the limbs, and enduring sensitivity to interpersonal rejection can accompany it. The term “atypical” is historical; this presentation is neither necessarily rare nor less serious than other forms of depression. A 2025 scoping review and the National Institute of Mental Health (NIMH) provide useful starting points for understanding its clinical significance.
The diagnostic distinction matters because experiencing a pleasant moment does not rule out depression. A person can laugh with a friend, enjoy good news, or feel temporarily hopeful and still have sustained changes in mood, energy, sleep, motivation, functioning, and health that warrant assessment. Treatment decisions depend on the underlying depressive disorder, episode severity, safety, prior response, comorbidities, and patient preferences—not on the word “atypical” alone.
Key Points
Atypical depression is a clinical descriptor, most precisely expressed as depression “with atypical features.” It is a specifier attached to a qualifying mood-disorder diagnosis or depressive presentation, not a separate disease identified by one symptom.
The DSM-style pattern requires mood reactivity plus at least two additional features: increased appetite or weight gain, hypersomnia, leaden paralysis, or enduring rejection sensitivity with meaningful functional consequences. A clinician also considers whether melancholic or catatonic features are present. Łojko and Rybakowski, 2017.
Oversleeping or emotional sensitivity alone cannot establish atypical features, and an online depression scale cannot distinguish this presentation reliably from medical, sleep-related, medication-related, or other psychiatric conditions. Zahra and colleagues, 2025.
Evidence-based depression care includes appropriate psychotherapy, medication when indicated, and follow-up. Older trials raised particular interest in monoamine oxidase inhibitors, but they do not establish a universal first-choice drug for everyone with atypical features. Jarrett and colleagues, 1999; VA/DoD guideline, 2022.
A careful assessment includes past periods of unusually high energy, reduced need for sleep, elevated or irritable mood, or other signs of hypomania or mania, because atypical features can also occur during bipolar depression. NIMH Bipolar Disorder.
I. What Does Atypical Depression Mean?
The word “atypical” comes from the historical effort to distinguish different depressive presentations, especially those featuring mood reactivity and “reversed vegetative” symptoms. In many depressive episodes people report insomnia and reduced appetite. In a presentation with atypical features, sleeping longer and eating more can be prominent. Those contrasts describe tendencies, not exclusive categories. Depression varies substantially across individuals and episodes. American Journal of Psychiatry historical review; Zahra et al., 2025.
In contemporary American diagnostic language, “with atypical features” modifies a qualifying depressive presentation. It helps communicate the pattern found during clinical evaluation. Major depressive disorder (MDD), a major depressive episode, persistent depressive disorder, clinical specifiers, and bipolar disorders remain different diagnostic concepts. A depressive symptom is an individual experience; an episode is a time-limited syndrome meeting clinical requirements; a disorder is the overall diagnosis; and a specifier adds descriptive detail. Readers needing the broader classification can consult Types of Depression: Diagnoses and Clinical Specifiers and Major Depressive Disorder: Symptoms and Diagnostic Criteria.
The label should also be distinguished from everyday phrases such as “unusual depression,” “functional depression,” or “smiling depression.” These phrases are sometimes used to describe outward behavior, but they do not substitute for the defined atypical-features criteria. A person's visible composure or ability to work says little by itself about diagnosis or severity.
II. The Clinical Criteria Explained
1. Mood Reactivity: The Central Feature
Mood reactivity means a person's mood brightens in response to an actual or anticipated positive event. Positive news, an enjoyable visit, encouragement, or another meaningful experience may bring a real but temporary improvement. The improvement is compatible with persisting depression before and after the event. Clinicians look for a pattern during the depressive period, considering examples, duration, context, and whether the improvement is genuine. Łojko and Rybakowski, 2017; Zahra et al., 2025.
Mood reactivity is different from having a complete recovery, an episodic burst of energy, or the heightened mood and activation associated with hypomania. It also differs from simply concealing sadness in social settings. A person who can feel pleased during a birthday celebration may remain substantially impaired by depression.
2. Increased Appetite or Weight Gain
Some people experience a noticeable increase in hunger, eating, food cravings, or weight during a depressive episode. What matters clinically is a meaningful change related to the course of illness, interpreted alongside medications, metabolic health, eating patterns, and other causes. Increased appetite is one of the four accompanying features, but it is neither mandatory on its own nor specific to depression. Posternak and Zimmerman, 2001.
3. Hypersomnia or Sleeping Much More Than Usual
Hypersomnia refers here to substantially increased sleep duration or an excessive need to sleep. It may include sleeping many hours and still feeling unrefreshed. Assessment must distinguish a real increase in sleep from time spent resting in bed, a delayed sleep schedule, shift-work effects, obstructive sleep apnea, medication-related sedation, or another sleep condition. Sleep quantity and sleep quality provide different clinical information. Zahra et al., 2025.
The separate article Depression and Sleep: Insomnia, Oversleeping, and Treatment develops the larger relationship between depression and sleep complaints.
4. Leaden Paralysis: Heavy Arms or Legs
“Leaden paralysis” is a historical clinical phrase for an intense, weighted-down sensation in the limbs, often described as if the arms or legs were made of lead. It concerns subjective physical heaviness and marked loss of vitality; it is not synonymous with the neurological inability to move. True sudden weakness, new asymmetry, inability to move, or other acute neurological changes warrant urgent medical evaluation rather than an assumption of depression. American Journal of Psychiatry review.
It can overlap with fatigue, but they are not identical experiences. A clinician will ask whether heaviness follows mood changes, whether it is continuous, and what other symptoms accompany it. For the broader symptom context, see Depression and Fatigue: Persistent Low Energy and Assessment.
5. Long-Standing Interpersonal Rejection Sensitivity
The final accompanying feature is a lasting pattern of unusually intense sensitivity to perceived rejection, criticism, or exclusion that causes significant difficulties in relationships, social participation, or work. In the clinical definition, this pattern extends beyond an isolated depressive episode. Feeling hurt after criticism is a normal human response; the criterion requires a more persistent, impairing pattern assessed in context. Łojko and Rybakowski, 2017.
Rejection sensitivity can coexist with anxiety, trauma-related responses, relational difficulties, and other experiences. Its presence does not establish a personality disorder or explain its own cause. Research also finds that the individual atypical features may have different demographic and clinical correlates rather than forming one perfectly uniform syndrome. Posternak and Zimmerman, 2001.
6. How the Features Are Combined
The standard DSM-derived definition requires mood reactivity together with at least two of the four additional features described above. Historically, the specifier also excludes a concurrent melancholic or catatonic presentation. The clinician must first establish an appropriate underlying mood diagnosis, assess duration and impairment, and consider competing explanations. The presence of two isolated symptoms does not independently create a depressive disorder. Łojko and Rybakowski, 2017; Zahra et al., 2025.
The criteria describe a clinical constellation; they do not constitute a self-test. A person may have increased appetite and sleep without qualifying for the specifier, while another may have mood reactivity, leaden heaviness, and long-standing rejection sensitivity without either appetite or sleep change. The required combination should be interpreted within a comprehensive assessment.
III. What Can Atypical Depression Feel Like in Everyday Life?
An illustrative example is a person who struggles for weeks with depressed mood, marked physical heaviness, disrupted routine, withdrawal, and difficulty concentrating. A friend invites them to dinner, and they enjoy the conversation and feel genuinely lighter for part of the evening. The next morning, the larger depressive pattern persists. The enjoyable evening is meaningful, but it does not invalidate the illness. Such examples explain the concept; only a clinical assessment can establish whether diagnostic criteria are met.
Another person might notice an early-evening urge to sleep, long weekends spent sleeping, increased appetite, and strong distress after perceived exclusion. These experiences may have multiple origins, including sleep disorders, medications, life circumstances, depression, or their interaction. A useful clinical account records what changed from the person's usual pattern, when it changed, how functioning was affected, and whether symptoms persisted. NIMH Depression.
Some people continue studying, caregiving, or working despite considerable distress. Others experience pronounced impairment. Functioning is graded, context-dependent, and sometimes maintained at considerable personal cost. Neither public cheerfulness nor a demanding schedule establishes or excludes the DSM specifier.
IV. Is Atypical Depression Common?
Despite the name, the atypical-features pattern has repeatedly been identified in a substantial minority of people with depressive illness. A 2017 review summarized widely varying estimates, with approximately 15–29% in some epidemiological studies and 18–36% in clinical studies. These are study-dependent estimates among defined depressed samples, not the prevalence of atypical depression in all Americans. Diagnostic definitions, recruitment, age, clinical setting, and measurement approach strongly influence the number. Łojko and Rybakowski, 2017.
The 2025 scoping review synthesized 56 publications involving 139,924 participants and highlighted variation in which symptoms researchers required and how features were measured. Most included studies were cross-sectional, making definitive causal or long-term predictive conclusions difficult. The review identified limitations in validated atypical-specific measurements. Thus, the best supported prevalence statement is that atypical features are clinically relevant and not necessarily rare, while estimates remain heterogeneous. Zahra et al., 2025.
Several observational studies associate this pattern with earlier onset, longer courses, certain metabolic characteristics, and other co-occurring conditions, but group associations cannot predict an individual patient's trajectory. The evidence base also varies in the ability to account for medication, diagnostic overlap, and recruitment. No single age, gender, personality style, body type, or lifestyle determines the specifier. Łojko and Rybakowski, 2017.
V. Causes, Biology, and Why the Pattern Appears
Depressive disorders arise through interacting biological, psychological, and social pathways. Familial susceptibility, stressful experiences, sleep and circadian disruption, health conditions, and contextual adversity may contribute to the likelihood and expression of a depressive illness. Current evidence does not establish one specific cause for atypical features or one biological test that diagnoses them. NIMH Depression; Zahra et al., 2025.
Researchers have investigated hypothalamic–pituitary–adrenal signaling, inflammation, leptin and appetite regulation, metabolism, sleep, and neurobiological differences from other depressive patterns. Some studies report subgroup-level contrasts, but results are mixed and methodological differences matter. These findings remain scientific hypotheses and correlates rather than routine diagnostic biomarkers or a basis for selecting treatment for a particular patient. Łojko and Rybakowski, 2017.
It is also tempting to explain rejection sensitivity as the cause of atypical depression, or mood reactivity as proof that depression is “situational.” Both inferences go beyond what the criteria show. The specifier describes features seen together; identifying direction of causality requires longitudinal and experimental evidence.
VI. How Clinicians Evaluate Atypical Features
A clinician begins with the full depressive history. Questions address mood, pleasure, energy, appetite, sleep, concentration, psychomotor changes, guilt, safety, the duration and timing of symptoms, interference with daily life, previous episodes, treatment exposures, and family history. The evaluation considers whether a major depressive episode is present, whether persistent depressive symptoms meet their own requirements, and whether any other disorder better accounts for the presentation. VA/DoD, 2022; NIMH Depression.
The clinician then asks about temporary mood brightening in response to positive events and each of the four accompanying features, seeking real examples and distinguishing enduring rejection sensitivity from a recent stressful event. They assess onset and course, other specifiers, current medication, substance use, and medical conditions. A diagnosis of MDD and the presence of atypical features answer related but distinct questions. Readers can follow the wider diagnostic pathway in Depression Diagnosis: What a Clinical Evaluation Includes.
A questionnaire such as the PHQ-9 can help detect or monitor depressive symptom burden when properly used. It does not establish atypical features and cannot replace a diagnostic interview. The 2025 review found inconsistent research approaches to identifying atypical depression and limited psychometric validation for dedicated instruments. Zahra et al., 2025. The distinction between a positive screen and a diagnosis is explained in Depression Screening: What a Positive Questionnaire Result Means.
Medical assessment is individualized. Depending on the presentation, a clinician may investigate sleep apnea, thyroid problems, anemia, medication effects, metabolic changes, or other conditions. Laboratory tests can clarify specific suspected contributors; there is no routine blood test that verifies the atypical-features specifier. NIMH Depression.
VII. Distinctions That Change the Diagnosis
1. Atypical Features and Melancholic Features
Melancholic features are another DSM depressive specifier, often involving pronounced loss of pleasure, limited mood response to positive experiences, early-morning awakening, psychomotor changes, and characteristic mood variation. Atypical features emphasize mood reactivity and some contrasting appetite and sleep changes. Individual symptoms overlap across depressive presentations, and neither label determines severity on its own. The specifier-level distinction is made within the broader evaluation, including the exclusion rules for concurrent melancholic and atypical features. CANMAT description of specifiers.
2. Persistent Depressive Disorder and Chronic Symptoms
Persistent depressive disorder (dysthymia) describes a chronic depressive course using duration and other diagnostic requirements. Atypical features describe a symptom pattern. Someone may have a chronic depressive disorder and a pattern of atypical symptoms; the descriptions answer different questions and should be assessed separately. Persistent Depressive Disorder (Dysthymia): Symptoms and Treatment discusses chronicity, diagnosis, and care.
3. Seasonal Patterns
Seasonal patterns concern the timing of mood episodes across recurring periods of the year. Changes in sleep and appetite may occur in seasonal depression, but hypersomnia and hyperphagia alone neither establish a seasonal pattern nor automatically establish atypical features. The seasonal specifier requires its own longitudinal assessment. NIMH Depression.
4. Bipolar Depression, Hypomania, and Mania
A person experiencing bipolar depression may also show atypical features. This makes a history of mania, hypomania, and mixed symptoms crucial. Clinicians ask about distinct periods of unusually increased energy or activity, markedly reduced need for sleep, behavioral changes, increased talkativeness, racing thoughts, impulsive behavior, and elevated or irritable mood. Transient pleasure in response to good news is not equivalent to hypomania. NIMH Bipolar Disorder.
This distinction affects medication decisions, since treatment approaches to bipolar depression differ from treatment for unipolar MDD. Antidepressant monotherapy may be inappropriate in some bipolar presentations, especially when manic or mixed symptoms are a concern. Screening for a bipolar history is part of responsible evaluation rather than a conclusion drawn from oversleeping or appetite changes alone. NIMH Bipolar Disorder; CANMAT MDD guidance.
5. Anxiety, Trauma, and Interpersonal Sensitivity
Anxiety conditions and trauma-related reactions can intensify vigilance to disapproval, avoidance, sleep disruption, and fatigue. Such overlap requires assessment of the complete syndrome and history rather than treating rejection sensitivity as a single-cause marker. Published cross-cluster English coverage includes Anxiety and Depression: Why They Commonly Co-Occur. The full diagnostic owner of anxiety disorders remains that cluster.
6. Physical Disorders and Sleep Conditions
Sleep disorders, endocrine disease, medication sedation, neurological problems, chronic illness, and eating-related conditions can produce features that resemble parts of the atypical pattern. Atypical features do not imply that these other explanations are impossible. They may coexist with depression and deserve separate evaluation when clinically indicated. New or severe physical symptoms, particularly sudden neurological deficits, should be evaluated as medical concerns. NIMH Depression.
VIII. Treatment: What the Evidence Supports
The principal treatment target is the depressive illness and its impact on daily life. Selecting care involves the episode's severity and duration, previous episodes, patient goals, access to treatment, adverse-effect vulnerability, medical comorbidities, pregnancy-related considerations where relevant, possible bipolarity, and current safety needs. Guidelines emphasize shared decision-making, appropriate psychotherapy and pharmacotherapy, measured treatment response, and follow-up. Atypical features add useful descriptive information but do not create a wholly separate treatment algorithm. VA/DoD MDD guideline, 2022; CANMAT updated guideline, 2024.
1. Psychotherapy
Evidence-based psychotherapy can help people with depression address depressive thoughts, withdrawal, avoidance, daily functioning, and interpersonal difficulties. Cognitive behavioral therapy and other supported approaches may be used according to the clinical situation and patient preferences. It is important to distinguish strong evidence for depression treatment generally from the smaller body of research specifically enrolling people with atypical features. NIMH Depression; VA/DoD, 2022.
A notable 1999 randomized study involving 108 outpatients with major depression and atypical features compared cognitive therapy, phenelzine, and pill placebo over 10 weeks. Reported response rates were 58% for cognitive therapy, 58% for phenelzine, and 28% for placebo using the study's specified outcome definition. This trial demonstrates that psychotherapy has direct research support in this subgroup, while its age, sample, duration, and specific treatments limit generalization to every patient or today's full range of therapies. Jarrett et al., 1999.
2. Antidepressants and Historical MAOI Findings
Modern depression care commonly considers antidepressants when clinically appropriate, together with psychotherapy or as part of a shared treatment plan. Choosing and monitoring medication requires attention to previous benefit, potential adverse effects, drug interactions, co-occurring conditions, and patient priorities. Individual response varies. CANMAT, 2024.
Research interest in atypical depression grew partly because earlier studies found that certain patients meeting historical atypical criteria responded better to phenelzine, a monoamine oxidase inhibitor (MAOI), than to the tricyclic antidepressant imipramine. This was evidence from particular trials and definitions, not proof that phenelzine or the MAOI class is the automatic first-line choice for contemporary patients. Quitkin et al., 1988; Łojko and Rybakowski, 2017.
MAOIs can have clinically significant drug–drug and food interactions, requiring specialist prescribing advice, dietary instructions for certain drugs, and careful plans when switching medications. Some serotonergic combinations can cause dangerous serotonin toxicity, and tyramine interactions with certain MAOIs can trigger severe hypertension. Current guidelines place MAOIs within a carefully supervised treatment context rather than recommending them for self-directed use. NICE depression guideline, section 1.9.
3. Monitoring and Medication Discontinuation
A reasonable treatment plan specifies what improvement would look like for that person: changes in mood, pleasure, sleep, appetite, energy, work or school, relationships, and safety. Clinicians assess adverse effects and whether medication, psychotherapy, or both are sufficiently helping; they then adjust the plan through shared decisions when needed. VA/DoD, 2022.
Stopping antidepressants abruptly can produce withdrawal symptoms for some people. Decisions about dose reduction, switching, or discontinuing are individualized with the prescriber, particularly when a drug has complex interaction or withdrawal considerations. A recurrence of depressive symptoms and medication withdrawal can sometimes be difficult to distinguish and deserve clinical assessment. NICE recommendations on stopping antidepressants.
4. Persistent Depression and Further-Line Care
If depression remains impairing after an adequate treatment attempt, clinicians reassess the initial diagnosis, treatment adequacy, adherence and adverse effects, co-occurring medical or psychiatric conditions, and access barriers. Further care might involve a different psychotherapy, a medication adjustment or switch, combined treatment, or specialist consultation. “Treatment-resistant depression” is a separate clinical concept with variable operational definitions; atypical features alone do not establish resistance. NICE guideline, further-line treatment; CANMAT, 2024.
Brain stimulation treatments, including repetitive transcranial magnetic stimulation and electroconvulsive therapy, and specialist interventions such as ketamine- or esketamine-based care may be considered in particular depressive conditions under professional protocols. Their indication, risk management, and evidence concern the patient's diagnosis and treatment history; there is insufficient basis to claim that atypical features alone identify a patient who should receive any one of these interventions. Electroconvulsive therapy may be considered for severe, life-threatening, or otherwise difficult-to-treat depression after an appropriate clinical evaluation. NICE guideline, ECT and TMS; VA/DoD, 2022.
5. Children, Teenagers, and Special Clinical Circumstances
Depression in children and adolescents requires developmentally appropriate evaluation, caregiver involvement when appropriate, attention to school functioning, and age-specific treatment and monitoring. Evidence from adult atypical-depression cohorts should not be copied directly into pediatric prescribing or diagnostic decisions. In young people starting antidepressants, clinicians pay particular attention to clinical monitoring and changes in suicidal thinking or behavior. NIMH Depression. See Depression in Teens: Symptoms, Screening, and Treatment.
Severe psychotic symptoms, signs of mania, inability to maintain adequate nutrition or hydration, or acute safety concerns change the urgency and setting of care. These circumstances require their own assessment and safety response, irrespective of whether atypical features are also reported. NICE guideline.
IX. Practical Steps for Someone Experiencing This Pattern
A useful first step is to record when symptoms began, how long they have persisted, and what has changed from the person's baseline. Specific examples can clarify temporary mood improvement after positive events, changes in eating and sleeping, the experience of limb heaviness, and reactions to rejection. Recording impairment is important: missed obligations, strained relationships, loss of interest, and difficulty managing basic routines help place symptoms in clinical context. These notes support a conversation with a licensed clinician; they are not a self-administered diagnostic instrument.
Schedule an assessment if depressive changes persist, worsen, or meaningfully disrupt life. Mention previous periods of unusually high energy, decreased need for sleep, or impulsive behavior, along with current medications, sleep problems, and physical symptoms. Share any family history of bipolar disorder or depression if known. Professional evaluation can clarify whether the main problem is a depressive disorder, a comorbidity, a medical issue, or a combination. NIMH Depression.
During treatment, consider consistent sleep and wake times, regular eating, realistic daily activity, supportive relationships, and reduction of avoidable barriers to care. Such practices may support functioning but do not replace a indicated clinical treatment. A plan adapted to current energy and disability is usually more sustainable than rigid self-imposed targets. The evidence for a specific medication or psychological intervention should be discussed in the context of the actual diagnosis and personal preferences. VA/DoD, 2022.
If thoughts of suicide, self-harm, or inability to stay safe arise, seek immediate local emergency assistance or crisis support. In the United States, call or text 988 to reach the Suicide & Crisis Lifeline. If immediate danger exists, call emergency services. The presence of occasional mood improvement does not make safety concerns less important. NIMH Depression.
X. Research Limitations and Open Questions
The clearest current evidence concerns the descriptive criteria and their repeated observation across clinical and epidemiological samples. The uncertain questions include exactly how best to measure the construct, which components are most predictive of course or response, how much overlap exists with other depression patterns, and whether biological differences will lead to validated, clinically useful stratification. Zahra et al., 2025.
Some researchers challenge the mandatory role of mood reactivity and question whether all five features belong to a single homogeneous group. The 2025 review found that many studies operationalized atypical depression differently, with too little evidence for a reliable independent self-report diagnostic test. These disagreements matter when interpreting prevalence estimates and subgroup-specific treatment results. Posternak and Zimmerman, 2001; Zahra et al., 2025.
Future research needs consistent diagnostic definitions, prospective studies of course and functional outcomes, better comparison of treatment options in well-characterized samples, and evaluation across different populations. As evidence develops, clinicians should continue to treat the person's full clinical presentation rather than drawing strong mechanistic conclusions from the specifier alone.
XI. Frequently Asked Questions
Is atypical depression a real diagnosis?
The formal clinical term is “with atypical features,” a recognized DSM specifier used with an appropriate mood-disorder diagnosis. It identifies a symptom pattern; it does not stand by itself as a separate diagnosis merely because someone reports oversleeping or increased appetite. Łojko and Rybakowski, 2017.
Does being able to feel happy mean I cannot be depressed?
No. Temporary positive mood in response to something good is the defining idea of mood reactivity. Depression is evaluated across the overall symptom history, severity, impairment, duration, and differential diagnosis. NIMH Depression.
What are the five atypical features?
The traditional formulation includes mood reactivity as the required feature, together with four possible accompanying features: increased appetite or weight, hypersomnia, leaden paralysis, and long-standing impairing rejection sensitivity. At least two of the four accompanying features are required for the DSM-derived specifier. Zahra et al., 2025.
Can I have atypical depression without overeating or oversleeping?
Potentially, yes: neither increased appetite nor hypersomnia is individually required if mood reactivity and at least two other qualifying accompanying features are present. The full depressive diagnosis, functional impact, and exclusions still require clinician evaluation. Łojko and Rybakowski, 2017.
Is atypical depression more or less severe than other depression?
The specifier describes a symptom configuration, not a severity grade. A person's episode can vary in severity and impairment, and risk must be evaluated separately. NIMH Depression.
Is atypical depression the same as high-functioning depression or smiling depression?
No. “High-functioning” and “smiling” are popular descriptive labels about outward presentation or maintained responsibilities, while atypical features have a defined diagnostic pattern. An outward smile can occur in many emotional and clinical circumstances.
Can atypical depression occur in bipolar disorder?
Yes, depressive episodes in bipolar disorders may have atypical features. The bipolar diagnosis is established from the overall history, especially mania or hypomania, and has different treatment implications. NIMH Bipolar Disorder.
Is there a best antidepressant for atypical depression?
There is no reliable universal first-choice medication based solely on the specifier. Historic MAOI trials are informative, but contemporary treatment needs individualized evaluation, shared decision-making, interaction assessment, and monitoring. Quitkin et al., 1988; CANMAT, 2024.
Can atypical depression go away?
Depressive symptoms can improve with appropriate care. Treatment response, remission, relapse, and recurrence should be evaluated over time. “Remission” concerns sustained improvement below the relevant symptom threshold; “relapse” generally refers to return during recovery from the same episode, while “recurrence” describes a subsequent episode after recovery. Long-term planning reflects the individual clinical course. NICE depression guideline.
Should I use an online atypical depression checklist?
A checklist can organize observations for a professional appointment, but current research finds inconsistent definitions and limited validation for dedicated atypical-depression assessment tools. Self-scoring should not be interpreted as a definitive specifier or diagnosis. Zahra et al., 2025.
Conclusion
Atypical depression is most accurately understood as depression with atypical features: a clinically recognized pattern involving mood reactivity and a specified combination of appetite, sleep, physical heaviness, and rejection-sensitivity findings. The label preserves a useful diagnostic distinction while requiring the same careful attention to episode criteria, functional impairment, differential diagnosis, bipolar history, patient safety, and evidence-based treatment that any depressive presentation deserves. Its meaning is clearest when the specifier is treated as one part of a complete clinical formulation.
Related Articles
References
Jarrett, R. B., Schaffer, M., McIntire, D., Witt-Browder, A., Kraft, D., & Risser, R. C. (1999). Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. Archives of General Psychiatry, 56(5), 431–437. https://doi.org/10.1001/archpsyc.56.5.431.
Lam, R. W., et al. (2024). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Canadian Journal of Psychiatry, 69(9), 641–687. https://doi.org/10.1177/07067437241245384.
Łojko, D., & Rybakowski, J. K. (2017). Atypical depression: Current perspectives. Neuropsychiatric Disease and Treatment, 13, 2447–2456. https://doi.org/10.2147/NDT.S147317.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations.
National Institute of Mental Health. (n.d.). Bipolar disorder. https://www.nimh.nih.gov/health/publications/bipolar-disorder.
National Institute of Mental Health. (n.d.). Depression. https://www.nimh.nih.gov/health/publications/depression.
Parker, G., Roy, K., Mitchell, P., Wilhelm, K., Malhi, G., & Hadzi-Pavlovic, D. (2002). Atypical depression: A reappraisal. American Journal of Psychiatry, 159(9), 1470–1479. https://doi.org/10.1176/appi.ajp.159.9.1470.
Posternak, M. A., & Zimmerman, M. (2001). Symptoms of atypical depression. Psychiatry Research, 104(2), 175–181. https://doi.org/10.1016/S0165-1781(01)00301-8.
Quitkin, F. M., et al. (1988). Phenelzine versus imipramine in the treatment of probable atypical depression: Defining syndrome boundaries of selective MAOI responders. American Journal of Psychiatry, 145(3), 306–311. https://doi.org/10.1176/ajp.145.3.306.
U.S. Department of Veterans Affairs and U.S. Department of Defense. (2022). VA/DoD clinical practice guideline for the management of major depressive disorder. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/mdd/index.asp.
Zahra, S. M., Whelan, T. A., Henry, D., Pizarro-Campagna, E., Anderson, J. R., & colleagues. (2025). Manifestation and measurement of atypical depression: A scoping review. Clinical Psychology & Psychotherapy, 32(4), e70123. https://doi.org/10.1002/cpp.70123.